To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of moving stem cell transplant recipients who have a non malignant blood disorder and who are clinically extremely vulnerable from covid-19 vaccine priority level six to four.
This answer is the replacement for a previous holding answer.
9 April 2021
People who have received a stem cell transplant more than six months ago are included within priority group six of phase one. People who have received a stem cell transplant within the last six months will be defined as clinically extremely vulnerable in which case they are included in priority group four. Both groups should now have been called forward for vaccination.